Modalis Therapeutics Corporation (TYO:4883)
33.00
0.00 (0.00%)
Aug 27, 2026, 3:30 PM JST
Modalis Therapeutics Employees
Modalis Therapeutics had 17 employees as of December 31, 2025. The number of employees increased by 3 or 21.43% compared to the previous year.
Employees
17
Change (1Y)
3
Growth (1Y)
21.43%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
3.44B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 17 | 3 | 21.43% |
| Dec 31, 2024 | 14 | -23 | -62.16% |
| Dec 31, 2023 | 37 | 1 | 2.78% |
| Dec 31, 2022 | 36 | 10 | 38.46% |
| Dec 31, 2021 | 26 | 6 | 30.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Transgenic Group | 227 |
| Kohjin Bio | 176 |
| Human Metabolome Technologies | 62 |
| Ribomic | 25 |
| Cyfuse Biomedical K.K. | 23 |
| D. Western Therapeutics Institute | 19 |
| TMS Co., Ltd. | 18 |
| Kringle Pharma | 17 |
Modalis Therapeutics News
- 1 year ago - SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy - Financial Post